Target- |
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Oct 2006 |
A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Adaptive Phase 3 Study to Evaluate the Efficacy and Safety of Sinecatechins (Defined Extract of Green Tea Leaves) Ointment in Adult Patients with Actinic Keratosis of the Scalp and the Face. - Pro_VER-01-21_AR
100 Clinical Results associated with Aresus Pharma GmbH
0 Patents (Medical) associated with Aresus Pharma GmbH
100 Deals associated with Aresus Pharma GmbH
100 Translational Medicine associated with Aresus Pharma GmbH